Intravenous chemoreduction or intra-arterial chemotherapy for cavitary retinoblastoma: Long-term results

Archives of Ophthalmology

Volumn 130, Issue 5, 2012, Pages 585-590

  Rojanaporn, Duangnate ^a   Kaliki, Swathi ^a   Bianciotto, Carlos G ^a   Iturralde, Juan C ^a   Say, Emil A ^a   Shields, Carol L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; MELPHALAN; VINCRISTINE SULFATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CAVITARY RETINOBLASTOMA; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; INTERVENTION STUDY; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; SALVAGE THERAPY; SUBRETINAL FLUID; TREATMENT RESPONSE; TUMOR RECURRENCE; TUMOR VOLUME; VITREOUS BODY;

ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD, PRESCHOOL; ETOPOSIDE; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INFANT; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MALE; MELPHALAN; OPHTHALMIC ARTERY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VINCRISTINE;

EID: 84860896365     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.2825     Document Type: Article

References (32)

1. Shields CL, Palamar M, Sharma P, et al. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors. Arch Ophthalmol. 2009;127(3):282-290.
2. Shields CL, Ramasubramanian A, Thangappan A, et al. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology. 2009;116(3):544.e1-551.e1. doi:10.1016/j.ophtha.2008.10.014.
3. Lumbroso-Le Rouic L, Aerts I, Lévy-Gabriel C, et al. Conservative treatments of intraocular retinoblastoma. Ophthalmology. 2008;115(8):1405-1410, 1410.e1-1410.e2. doi:10.1016/j.ophtha.2007.11.009.
4. Menon BS, Juraida E, Alagaratnam J, et al. Chemoreduction for intraocular retinoblastoma in Malaysia. J Pediatr Hematol Oncol. 2007;29(1):2-4. (Pubitemid 46143018)
5. Gombos DS, Chevez-Barrios AP. Current treatment and management of retinoblastoma. Curr Oncol Rep. 2007;9(6):453-458. (Pubitemid 350081481)
6. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113(12):2276-2280. (Pubitemid 44838917)
7. Antoneli CB, Ribeiro KC, Steinhorst F, Novaes PE, Chojniak MM, Malogolowkin M. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol. 2006;28(6):342-345. (Pubitemid 43970388)
8. Shields JA, Shields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am J Ophthalmol. 2005;140(3):505-506. (Pubitemid 41224843)
9. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol. 2004;138(3):329-337. (Pubitemid 39208559)
10. Shields CL, Mashayekhi A, Demirci H, Meadows AT, Shields JA. Practical approach to management of retinoblastoma. Arch Ophthalmol. 2004;122(5):729-735. (Pubitemid 38596253)
11. Moll AC, Imhof SM, Schouten-van Meeteren AY, Boers M, van Leeuwen F, Hofman P. Chemoreduction for retinoblastoma [comment]. Arch Ophthalmol. 2003;121(10):1513. (Pubitemid 37243769)
12. Sussman DA, Escalona-Benz E, Benz MS, et al. Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol. 2003;121(7):979-984. (Pubitemid 36841789)
13. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol. 2002;120(12):1653-1658. (Pubitemid 36401799)
14. Ghose S, Nizamuddin SH, Sethi A, et al. Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities. J Pediatr Ophthalmol Strabismus. 2002;39(3):143-150. (Pubitemid 36443420)
15. Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18(1):12-17. (Pubitemid 30036331)
16. Greenwald MJ, Goldman S, Strauss LC. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1998;105(9):1579-1581. (Pubitemid 28513499)
17. Shields CL, Shields JA, Needle M, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104(12):2101-2111. (Pubitemid 28053438)
18. Murphree AL, Villablanca JG, Deegan WF III, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114(11):1348-1356. (Pubitemid 26398720)
19. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114(11):1330-1338. (Pubitemid 26398718)
20. Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129(6):732-737.
21. Shields CL, Shields JA. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Clin Experiment Ophthalmol. 2010;38(6):638-643.
22. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010;117(8):1623-1629.
23. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol. 2011;129(11):1399-1406.
24. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications. Arch Ophthalmol. 2011;129(11):1407-1415.
25. Aziz HA, Boutrid H, Murray TG, et al. Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma. Retina. 2010;30(4)(suppl):S63- S65.
26. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21(3):203-212.
27. Mashayekhi A, Shields CL, Eagle RC Jr, Shields JA. Cavitary changes in retinoblastoma: relationship to chemoresistance. Ophthalmology. 2005;112(6):1145-1150. (Pubitemid 40797474)
28. Palamar M, Pirondini C, Shields CL, Shields JA. Cavitary retinoblastoma: ultrasonographic and fluorescein angiographic findings in 3 cases. Arch Ophthalmol. 2008;126(11):1598-1600.
29. Ts'o MO, Zimmerman LE, Fine BS. The nature of retinoblastoma, I: photoreceptor differentiation: a clinical and histopathologic study. Am J Ophthalmol. 1970;69(3):339-349.
30. Ginsberg J, Spaulding AG, Asbury T. Cystic retinoblastoma. Am J Ophthalmol. 1975;80(5):930-934.
31. Demirci H, Eagle RC Jr, Shields CL, Shields JA. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction. Arch Ophthalmol. 2003;121(8):1125-1131. (Pubitemid 36962166)
32. Shields CL, Mashayekhi A, Cater J, et al. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Arch Ophthalmol. 2005;123(6):765-773. (Pubitemid 41056597)